These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26722955)

  • 1. Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients.
    Guppy KH; Harris J; Chen J; Paxton EW; Alvarez J; Bernbeck J
    J Neurosurg Spine; 2016 Apr; 24(4):556-64. PubMed ID: 26722955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients.
    Guppy KH; Harris J; Chen J; Paxton EW; Bernbeck JA
    J Neurosurg Spine; 2016 Sep; 25(3):309-17. PubMed ID: 27104284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does bone morphogenetic protein change the operative nonunion rates in spine fusions?
    Guppy KH; Paxton EW; Harris J; Alvarez J; Bernbeck J
    Spine (Phila Pa 1976); 2014 Oct; 39(22):1831-9. PubMed ID: 25299166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation for Symptomatic Nonunions in Atlantoaxial (C1-C2) Fusions with and without Bone Morphogenetic Protein: A Cohort of 108 Patients with >2 Years Follow-Up.
    Guppy KH; Lee DJ; Harris J; Brara HS
    World Neurosurg; 2019 Jan; 121():e458-e466. PubMed ID: 30267948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the use of preoperative bisphosphonates in patients with osteopenia and osteoporosis affect lumbar fusion rates? Analysis from a national spine registry.
    Guppy KH; Chan PH; Prentice HA; Norheim EP; Harris JE; Brara HS
    Neurosurg Focus; 2020 Aug; 49(2):E12. PubMed ID: 32738794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reoperation Rates for Symptomatic Nonunions in Anterior Cervical Fusions From a National Spine Registry.
    Guppy KH; Harris J; Paxton LW; Alvarez JL; Bernbeck JA
    Spine (Phila Pa 1976); 2015 Oct; 40(20):1632-7. PubMed ID: 26261916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
    Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
    Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in reoperation rates for nonunions (operative nonunions) in posterior cervical fusions stopping at C7 versus T1/2: a cohort of 875 patients.
    Guppy KH; Royse KE; Fennessy JH; Norheim EP; Harris JE; Brara HS
    J Neurosurg Spine; 2022 Jun; 36(6):979-985. PubMed ID: 34952515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLF+PS or ALIF+PS: which has a lower operative nonunion rate? Analysis of a cohort of 2,061 patients from a National Spine Registry.
    Norheim EP; Royse KE; Brara HS; Moller DJ; Suen PW; Rahman SU; Harris JE; Guppy KH
    Spine J; 2021 Jul; 21(7):1118-1125. PubMed ID: 33640585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLF Versus PLIF and the Fate of L5-S1: Analysis of Operative Nonunion Rates Among 3065 Patients with Lumbar Fusions from a Regional Spine Registry.
    Guppy KH; Royse KE; Norheim EP; Harris JE; Brara HS
    Spine (Phila Pa 1976); 2021 May; 46(10):E584-E593. PubMed ID: 33306615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
    Cahill KS; Chi JH; Day A; Claus EB
    JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occipitocervical Fusions in Elderly Patients: Mortality and Reoperation Rates From a National Spine Registry.
    Guppy KH; Brara HS; Bernbeck JA
    World Neurosurg; 2016 Feb; 86():161-7. PubMed ID: 26433097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operative Nonunion Rates in Posterolateral Lumbar Fusions: Analysis of a Cohort of 2591 Patients from a National Spine Registry.
    Guppy KH; Royse KE; Norheim EP; Moller DJ; Suen PW; Rahman SU; Harris JE; Brara HS
    World Neurosurg; 2021 Jan; 145():e131-e140. PubMed ID: 33010511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
    Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.
    Goode AP; Richardson WJ; Schectman RM; Carey TS
    Spine J; 2014 Sep; 14(9):2051-9. PubMed ID: 24321129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF; Jones CB; Sietsema DL
    Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.